Comment on 'Testing for ALK rearrangement in lung adenocarcinoma: A multicenter comparison of immunohistochemistry and fluorescent in situ hybridization'

Modern Pathology

Volumn 27, Issue 10, 2014, Pages 1423-1424

  Mahe, Etienne ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PROTEIN TYROSINE KINASE;

CANCER DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LETTER; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; ADENOCARCINOMA; FEMALE; GENETICS; LUNG TUMOR; MALE; PROCEDURES;

ADENOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84929938651     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2014.56     Document Type: Letter

References (4)

1. Selinger CI, Rogers TM, Russell PA, et al. Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol 2013;26:1545-1553.
2. Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J 2003;20:453-458.
3. Altman DG, Barton S, Begg CB, et al. STARD Statement: STAndards for the Reporting of Diagnostic accuracy studies. http://www.stard-statement.org/. Accessed 31 December 2013 2013.
4. Khandwala FT, Newton K, Wong D, et al. Statistics Calculator. 2004; http://ktclearinghouse.ca/cebm/toolbox/statscalc. Accessed 31 December 2013 2013.